RESUMO
The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout non-obese diabetic mice shares clinical and histological features with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Secondary axonal loss is prominent in the progressive phase of this neuropathy. Neurotrophin 3 (NT-3) is an important autocrine factor supporting Schwann cell survival and differentiation and stimulates neurite outgrowth and myelination. The anti-inflammatory and immunomodulatory effects of NT-3 raised considerations of potential efficacy in the SAPP model that could be applicable to CIDP. For this study, scAAV1.tMCK.NT-3 was delivered to the gastrocnemius muscle of 25-week-old SAPP mice. Measurable NT-3 levels were found in the serum at 7-week postgene delivery. The outcome measures included functional, electrophysiological and histological assessments. At week 32, NT-3-treated mice showed increased hind limb grip strength that correlated with improved compound muscle action potential amplitude. Myelinated fiber density was 1.9 times higher in the NT-3-treated group compared with controls and the number of demyelinated axons was significantly lower. The remyelinated nerve fiber population was significantly increased. These improved histopathological parameters from scAAV1.tMCK.NT-3 treatment occurred in the setting of reduced sciatic nerve inflammation. Collectively, these findings suggest a translational application to CIDP.
Assuntos
Doenças Autoimunes/terapia , Terapia Genética/métodos , Vetores Genéticos , Neurotrofina 3/genética , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/terapia , Animais , Doenças Autoimunes/genética , Células Dendríticas/metabolismo , Dependovirus/genética , Modelos Animais de Doenças , Masculino , Camundongos , Neurotrofina 3/sangue , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/genética , Células de SchwannRESUMO
Duchenne muscular dystrophy is a monogenic disease potentially treatable by gene replacement. Use of recombinant adeno-associated virus (AAV) will ultimately require a vascular approach to broadly transduce muscle cells. We tested the impact of preexisting AAV antibodies on microdystrophin expression following vascular delivery to nonhuman primates. Rhesus macaques were treated by isolated limb perfusion using a fluoroscopically guided catheter. In addition to serostatus stratification, the animals were placed into one of the three immune suppression groups: no immune suppression, prednisone, and triple immune suppression (prednisone, tacrolimus, and mycophenolate mofetil). The animals were analyzed for transgene expression at 3 or 6 months. Microdystrophin expression was visualized in AAV, rhesus serotype 74 sero-negative animals (mean: 48.0 ± 20.8%) that was attenuated in sero-positive animals (19.6 ± 18.7%). Immunosuppression did not affect transgene expression. Importantly, removal of AAV binding antibodies by plasmapheresis in AAV sero-positive animals resulted in high-level transduction (60.8 ± 18.0%), which is comparable with that of AAV sero-negative animals (53.7 ± 7.6%), whereas non-pheresed sero-positive animals demonstrated significantly lower transduction levels (10.1 ± 6.0%). These data support the hypothesis that removal of AAV binding antibodies by plasmapheresis permits successful and sustained gene transfer in the presence of preexisting immunity (natural infection) to AAV.
Assuntos
Dependovirus/imunologia , Distrofina/genética , Expressão Gênica , Vetores Genéticos/genética , Vetores Genéticos/imunologia , Plasmaferese , Animais , Anticorpos Neutralizantes/imunologia , Anticorpos Antivirais/imunologia , Dependovirus/genética , Genes Reporter , Vetores Genéticos/administração & dosagem , Proteínas de Fluorescência Verde/genética , Humanos , Macaca mulatta , Masculino , Músculo Esquelético/metabolismo , Plasmaferese/métodos , Transdução Genética , TransgenesRESUMO
This study investigated the function of the adhesion molecule L1 in unmyelinated fibers of the peripheral nervous system (PNS) by analysis of L1- deficient mice. We demonstrate that L1 is present on axons and Schwann cells of sensory unmyelinated fibers, but only on Schwann cells of sympathetic unmyelinated fibers. In L1-deficient sensory nerves, Schwann cells formed but failed to retain normal axonal ensheathment. L1-deficient mice had reduced sensory function and loss of unmyelinated axons, while sympathetic unmyelinated axons appeared normal. In nerve transplant studies, loss of axonal-L1, but not Schwann cell-L1, reproduced the L1-deficient phenotype. These data establish that heterophilic axonal-L1 interactions mediate adhesion between unmyelinated sensory axons and Schwann cells, stabilize the polarization of Schwann cell surface membranes, and mediate a trophic effect that assures axonal survival.
Assuntos
Axônios/metabolismo , Glicoproteínas de Membrana/metabolismo , Bainha de Mielina/metabolismo , Moléculas de Adesão de Célula Nervosa/metabolismo , Neurônios Aferentes/citologia , Células de Schwann/citologia , Animais , Axônios/ultraestrutura , Adesão Celular , Polaridade Celular , Sobrevivência Celular , Feminino , Gânglios Espinais/citologia , Gânglios Espinais/metabolismo , Deleção de Genes , Complexo Antígeno L1 Leucocitário , Masculino , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Knockout , Bainha de Mielina/ultraestrutura , Glicoproteína Associada a Mielina/genética , Glicoproteína Associada a Mielina/metabolismo , Degeneração Neural , Fibras Nervosas/metabolismo , Fibras Nervosas/ultraestrutura , Moléculas de Adesão de Célula Nervosa/genética , Neurônios Aferentes/metabolismo , Neurônios Aferentes/ultraestrutura , Sistema Nervoso Periférico/citologia , Pressão , Células de Schwann/metabolismo , Células de Schwann/ultraestrutura , Nervo Isquiático/transplante , Nervo Isquiático/ultraestruturaRESUMO
This study describes, for the first time, the neuropathy of zinc pyridinethione (ZPT) toxicity in rats. Although hind-limb weakness has been previously reported as a consequence of dietary ZPT ingestion in rats and rabbits, the cause of the paralysis has been unexplained. Sequential morphologic studies in rats fed a diet containing 166 ppm of ZPT revealed a dying-back neuropathy characterized by the early accumulation of tubulo-vesicular profiles in the motor nerve terminals. Continued exposure resulted in similar abnormalities in the intrasmuscular nerves and later in the peroneal and posterior tibial nerves and nerve branches to individual muscles. Axonal degeneration and regeneration followed the initial pathologic changes. There was relative sparing of the sensory nerve terminals of the muscle spindles. Central nervous system axons in the long descending tracts of the spinal cord and in the cerebellar vermis showed similar but quantitatively fewer axonal changes compared to the peripheral nerves. The central effects occurred only after prolonged administration of ZPT.
Assuntos
Compostos Organometálicos/toxicidade , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Piridinas/toxicidade , Zinco/toxicidade , Animais , Membro Posterior/inervação , Masculino , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/ultraestrutura , Músculos/inervação , Degeneração Neural/efeitos dos fármacos , Paralisia/induzido quimicamente , Paralisia/patologia , Doenças do Sistema Nervoso Periférico/patologia , Nervo Fibular/efeitos dos fármacos , Nervo Fibular/patologia , Ratos , Reflexo/efeitos dos fármacos , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/patologia , Células Receptoras Sensoriais/efeitos dos fármacos , Nervo Tibial/efeitos dos fármacos , Nervo Tibial/patologiaRESUMO
The fate of Schwann cells in Charcot-Marie-Tooth (CMT) neuropathies was addressed in this study of nerve biopsies from patients with proven PMP22 duplications and deletions. In frozen sections, apoptotic nuclei were detected using the TUNEL method. In adjacent sections, anti-neurofilament 68kD antibody was used as an axonal marker, while the antibodies to NKH-1 and low-affinity nerve growth factor receptor P75NTR were used as Schwann cell markers. In addition, plastic sections were used to determine the densities of myelinated fibers and Schwann cell nuclei. In all biopsies from CMT1A, TUNEL-positive nuclei appeared in clusters. In adjacent sections, areas of TUNEL-positive nuclei matched with areas devoid of neurofilaments and NKH-1-positive Schwann cell silhouettes, suggesting that the apoptotic nuclei belonged to nonmyelinating Schwann cells. In addition, quantitative studies on plastic-embedded sections showed a significantly reduced number of total Schwann cells compared with controls, strongly favoring a loss of Schwann cell by apoptosis. In HNPP, the number of total Schwann cells was increased and a significant Schwann cell apoptosis was observed in only 2 patients. Examination of plastic sections and teased nerve preparations from these cases suggested that the Schwann cell apoptosis might be related to the regenerative state of the nerve resulting from the process of sprout pruning. No strict correlation between p75NTR expression and apoptosis was found. These studies indicate that factors regulating Schwann cell number in early postnatal development continue to be important for Schwann cell survival throughout life.
Assuntos
Apoptose , Doença de Charcot-Marie-Tooth/patologia , Células de Schwann/patologia , Adulto , Idoso , Biópsia , Biotina , Comunicação Celular/fisiologia , Doença de Charcot-Marie-Tooth/genética , Fragmentação do DNA , Nucleotídeos de Desoxiuracil , Humanos , Microscopia Eletrônica , Pessoa de Meia-Idade , Família Multigênica , Proteínas da Mielina/genética , Bainha de Mielina/patologia , Bainha de Mielina/ultraestrutura , Neurônios/patologia , Neurônios/ultraestrutura , Células de Schwann/ultraestrutura , Coloração e RotulagemRESUMO
The content and distribution of cathepsin D, a lysosomal acidic endopeptidase, were determined by immunochemical methods in rat sciatic nerve near the site of a ligature or after exposure of animals to neurotoxins. In normal sciatic nerve, cathepsin D was localized predominantly in the perinuclear regions of Schwann cells. In ligated nerve, cathepsin D increased equally in both the proximal and distal nerve segments adjacent to the ligature. Although orthograde and retrograde axonal transport of cathepsin D may have contributed to this increase, immunocytochemical methods indicated that Schwann cells or other phagocytic cells accounted for the bulk of the increased cathepsin D content of nerve. Axonal function was nontraumatically altered by the administration of 2,5-hexanedione, acrylamide, B,B'-iminodipropionitrile or zinc pyridinethione. Exposure to any of these neurotoxins raised cathepsin D content throughout the sciatic nerve twofold or more, and greater amounts of immunoreactive cathepsin D in the cytoplasm of Schwann cells could be demonstrated immunocytochemically. These results indicate that changes in cathepsin D content of Schwann cells may be a reflection of their catabolic activity. The increased Schwann cell cathepsin D content in toxic axonopathies is further proof for an enhanced Schwann cell role as a phagocyte resulting from axonal injury.
Assuntos
Catepsinas/análise , Nervo Isquiático/análise , Animais , Transporte Axonal/efeitos dos fármacos , Catepsina D , Catepsinas/fisiologia , Ligadura , Masculino , Neurotoxinas/farmacologia , Ratos , Ratos Endogâmicos , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/fisiologia , Nervo Isquiático/ultraestruturaRESUMO
The pathogenesis of the selective motor neuron death in spinal bulbar muscular atrophy (SBMA) is not fully understood. Similar to observations with other mutant polyglutamine (poly Q) expanded proteins, truncated androgen receptor (AR) with expanded poly Q tract cause intracellular aggregates; however, the precise relationship between aggregates and disease pathogenesis is unresolved. In order to have a better understanding of the cellular processing and toxicity of the mutant AR, we focused on a short N-terminal portion of AR containing normal or expanded poly Q repeats, and have carried out biochemical, immunocytochemical, cytochemical and ultrastructural studies of BHK cells at different intervals after transfection. In cells expressing mutant truncated AR, using an anti-AR N-terminal antibody, we observed no immune staining in the nucleus and identified immune negative aggregates surrounded by immunopositive material in the cytoplasm. Congo red staining identified a component of aggregates with a beta-pleated secondary structure in both cytosol and nucleus, while electron microscopy revealed a fibrillary-granular material as the ultrastructural correlate. In addition, acid phosphatase staining and ubiquitin immunocytochemistry demonstrated that in transfected cells, both lysosomal and nonlysosomal degradation systems are actively involved in handling the mutant truncated AR. The temporal relationship of nuclear congophilia to a subsequent massive cell death suggests that entry of proteolytic cleavage products into the nucleus, perhaps the expanded poly Q stretch itself, may play an important role in cell toxicity.
Assuntos
Membranas Intracelulares/metabolismo , Fragmentos de Peptídeos/toxicidade , Receptores Androgênicos/química , Receptores Androgênicos/metabolismo , Animais , Morte Celular , Linhagem Celular/fisiologia , Núcleo Celular/fisiologia , Corantes , Vermelho Congo , Cricetinae , Citoplasma/fisiologia , Citoplasma/ultraestrutura , Escherichia coli/metabolismo , Gliceraldeído-3-Fosfato Desidrogenases/antagonistas & inibidores , Imuno-Histoquímica , Lisossomos/metabolismo , Receptores Androgênicos/genética , TransfecçãoRESUMO
Inclusion body myositis (IBM) represents a serious debilitating disease of muscle without identifiable cause or treatment. Muscle biopsy specimens have characteristic rimmed vacuoles, varying degrees of inflammation, and, most importantly, cytoplasmic and intranuclear filamentous inclusions of unknown composition. Fresh-frozen sections of muscle biopsy specimens from 24 IBM cases were stained with Congo red dye (pH, 10.5 to 11.0). Control biopsy specimens included polymyositis, dermatomyositis, hereditary vacuolar myopathies of unknown cause, acid maltase deficiency, distal myopathy, oculopharyngeal dystrophy, and chloroquine myopathy. Sections were also immunostained with antibody to transthyretin, human P component, and immunoglobulin light chains. In the vacuolated fibers in IBM, amyloidogenic green-birefringent deposits were seen. Some deposits were delicate and wispy appearing, and others were plaque-like. The size of deposits varied, measuring 1 x 2 to 8 microns, and rarely up to 20 microns in length. The number of amyloid-positive fibers correlated with the number of vacuolated fibers. Similar deposits were seen in one case of distal myopathy and one hereditary vacuolar myopathy. Other control cases were negative for amyloid deposits. Antibody staining for known amyloidogenic proteins was negative. This study demonstrates that the filaments in IBM share properties with amyloid proteins. The location implies that this amyloid material is formed intracellularly, rather than having a systemic derivation. The association of amyloid deposits with autophagic vacuoles in IBM raises the likely possibility that the filaments represent a modification of a normal protein within an acidic degradative vacuolar compartment. An alternative possibility, considering the shared properties of IBM filaments and prions (which include size and amyloidogenic properties), is that IBM represents a human prion disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Amiloide/análise , Corpos de Inclusão/patologia , Miosite/patologia , Adulto , Idoso , Feminino , Humanos , Corpos de Inclusão/química , Filamentos Intermediários/química , Filamentos Intermediários/patologia , Masculino , Pessoa de Meia-Idade , Doenças Musculares/metabolismo , Doenças Musculares/patologia , Miosite/metabolismo , Vacúolos/patologiaRESUMO
Taxol has recently been approved for the treatment of ovarian cancer that has failed to respond to other chemotherapeutic agents. A predominantly sensory neuropathy has been reported in patients receiving taxol, but corresponding nerve changes have not been described. The patient described herein received taxol at a dose of 275 mg/m2 every 21 days. The sural nerve biopsy performed after 17 courses of taxol (cumulative dose, 6603 mg) showed severe nerve fiber loss, axonal atrophy, and secondary demyelination. Axonal regeneration was absent. The findings are compatible with a cell body disease or a length-dependent, distal neuropathy with failure of axonal regeneration. The findings observed in taxol-induced neuropathy are important to document for comparison with other neoplastic and paraneoplastic neuropathies affecting patients with cancer.
Assuntos
Paclitaxel/efeitos adversos , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Nervo Sural/patologia , Eletrodiagnóstico , Feminino , Humanos , Pessoa de Meia-Idade , Doenças do Sistema Nervoso Periférico/patologiaRESUMO
A group of 17 patients had proximal diabetic neuropathy characterized by abrupt onset of asymmetric pain and weakness. Fourteen patients had unilateral onset that later involved the other extremity in 3 days to 8 months. All patients reported stepwise or steady progression during 2 to 18 months that was documented during serial examinations. In 16 patients, both proximal and distal muscles were involved. Sural nerve biopsy specimens demonstrated multifocal variability in nerve fiber density manifesting as nonrandom fiber loss between and within fascicles compared with age-matched controls. These findings demonstrate that patients may have a rapidly evolving course of proximal diabetic neuropathy followed by continued progression for many months and emphasize the overlap between proximal diabetic neuropathies of presumed different types. Our cases and others cast doubt on notions supporting two distinct types of proximal diabetic neuropathies represented by the rapid evolution of asymmetric weakness on an ischemic basis, in contrast to a more slowly progressive condition of metabolic pathogenesis.
Assuntos
Complicações do Diabetes , Doenças Musculares/etiologia , Potenciais de Ação , Idoso , Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Neuropatias Diabéticas/complicações , Neuropatias Diabéticas/fisiopatologia , Feminino , Quadril , Humanos , Perna (Membro) , Masculino , Pessoa de Meia-Idade , Doenças Musculares/patologia , Doenças Musculares/fisiopatologia , Dor/etiologia , Nervos Periféricos/patologia , Nervos Periféricos/fisiopatologia , SíndromeRESUMO
OBJECTIVE: To determine if response to immunosuppressive treatment in motor neuron syndromes could be predicted on the basis of clinical features, anti-GM1 antibodies, or conduction block. DESIGN: Prospective, uncontrolled, treatment trial using prednisone for 4 months followed by intravenous cyclophosphamide (3 g/m2) continued orally for 6 months. SETTING: All patients were referred to university hospital medical centers. PATIENTS: Sixty-five patients with motor neuron syndromes were treated with prednisone; 11 patients had elevated GM1 antibody titers, and 11 patients had conduction block. Forty-five patients received cyclophosphamide, eight of whom had elevated GM1 antibodies and 10 had conduction block. RESULTS: One patient responded to prednisone, and five patients responded to cyclophosphamide treatment. Only patients with a lower motor neuron syndrome and conduction block improved with either treatment. Response to treatment did not correlate with GM1 antibodies. CONCLUSIONS: GM1 antibodies did not serve as a marker for improvement in patients with motor neuron syndrome treated with immunosuppressive drugs. Patients with amyotrophic lateral sclerosis failed to improve irrespective of laboratory findings.
Assuntos
Ciclofosfamida/uso terapêutico , Doença dos Neurônios Motores/tratamento farmacológico , Prednisona/uso terapêutico , Adulto , Idoso , Esclerose Lateral Amiotrófica/tratamento farmacológico , Esclerose Lateral Amiotrófica/imunologia , Feminino , Gangliosídeo G(M1)/análise , Humanos , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Doença dos Neurônios Motores/imunologia , Doença dos Neurônios Motores/fisiopatologia , Condução Nervosa , Estudos ProspectivosRESUMO
BACKGROUND: Hereditary neuropathy with liability to pressure palsies (HNPP) in most cases is caused by a deletion in chromosome 17p11.2-12 or, rarely, mutations resulting in a functional loss of one copy of the peripheral myelin protein 22 (PMP22) gene. Point mutations that lie deep within transmembrane (TM) domains causing major structural changes in PMP22 are associated with severe neuropathy. METHODS: A 25-year-old asymptomatic woman with a normal neurologic examination volunteered as a control subject. Electrophysiologic studies showed multiple entrapment neuropathies, prompting a search for a genetic defect. In addition, sural nerve fascicles from the subject were grafted into the cut ends of the sciatic nerve of nude mice and studied at 2, 6, and 8 weeks and compared with controls. RESULTS: Direct sequencing of the PMP22 gene revealed a G-->A transition at position 202 in axon 3 of the PMP22 gene. To determine if this was a causative mutation rather than a polymorphism, 102 DNA samples from controls were studied; none showed a similar base pair change. In the nerve xenografts, there was a marked delay at the onset of myelination and an impairment in the regenerative capacity of the nude mice axons engulfed by the mutant human Schwann cells. The axon tips were enlarged and demonstrated neurofilament density increase. Neurofilament density distribution histograms were bimodal in xenografts as well as in the subject's sural nerve. CONCLUSION: This study provides unequivocal evidence that a base pair change causing a Val30Met substitution at the junction of the first TM domain and the extracellular loop of PMP22 results in the HNPP phenotype.
Assuntos
Doença de Charcot-Marie-Tooth/genética , Proteínas da Mielina/genética , Paresia/genética , Adulto , Animais , Doença de Charcot-Marie-Tooth/fisiopatologia , Cromossomos Humanos Par 17 , Feminino , Humanos , Masculino , Camundongos , Camundongos Nus , Microscopia Eletrônica , Proteínas de Neurofilamentos/ultraestrutura , Paresia/fisiopatologia , Linhagem , Mutação Puntual , Polimorfismo Conformacional de Fita Simples , Pressão/efeitos adversos , Nervo Sural/patologia , Nervo Sural/transplante , Nervo Sural/ultraestrutura , Transplante HeterólogoRESUMO
Three patients with mitochondrial myopathies and progressive external ophthalmoplegia had repeated episodes of respiratory failure requiring assisted ventilation. Studies in these patients and asymptomatic family members, as well as a sporadic case of Kearns-Sayre syndrome, demonstrated markedly depressed ventilatory drive responses to hypoxia. In 2 patients, there was also decreased drive to hypercapnia. The reduced ventilatory drive appears to be due to an altered neural control system that may cause episodic life-threatening hypoventilation occurring especially in relation to surgery, sedation, or intercurrent infection.
Assuntos
Mitocôndrias Musculares , Doenças Musculares/fisiopatologia , Oftalmoplegia/fisiopatologia , Insuficiência Respiratória/fisiopatologia , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Recidiva , Respiração Artificial/métodos , Testes de Função RespiratóriaRESUMO
Study of creatine phosphokinase (CPK) isoenzymes using a quantitative column chromatographic technique showed that there was a significant difference in serum MB isoenzyme activity between patients with Duchenne muscular dystrophy (42 mU per milliter) and those with other kinds of neuromuscular diseases (8 mU per milliter). In the Duchenne patients, the serum MB isoenzyme activity did not correlate with clinical cardiac disease. Furthermore, skeletal muscle damage produced in the rat by aortic ligation and 5-hydroxytryptamine resulted in significant elevations of plasma MB isoenzyme activty. These studies suggest that the serum MB isoenzyme activity in the Duchenne muscular dystrophy patients is probably arising from skeletal, not cardiac muscle and may reflect a distinct pathogenesis from other kinds of neuromuscular disorders.
Assuntos
Creatina Quinase/análise , Isoenzimas/análise , Distrofias Musculares/enzimologia , Animais , Creatina Quinase/sangue , Feminino , Coração/fisiopatologia , Humanos , Isoenzimas/sangue , Músculos/enzimologia , Distrofias Musculares/fisiopatologia , RatosRESUMO
A generalized toxic polyneuropathy was identified in a 23-year-old woman after excessive intentional inhalation of compressed N2O delivery from cartridges through a whipped-cream dispenser. The chronology of the patient's N2O abuse correlated clearly with two episodes of recurrent polyneuropathy. The toxic effects were limited to the nervous system, primarily involving the peripheral nerves, although some signs suggested a possible effect on the cerebellum or its connections. The findings on sural nerve biopsy were nonspecific, characterized principally by axonal degeneration. Gas chromatographic analysis of the N2O cartridges dispensed through the whipped-cream canister revealed an exposure to N2O and 26 other compounds. Three of these, trichloroethylene, toluene, and phenol, are known neurotoxins.
Assuntos
Óxido Nitroso/intoxicação , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Transtornos Relacionados ao Uso de Substâncias , Adulto , Laticínios , Eletromiografia , Feminino , Humanos , Condução Nervosa , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/patologia , Nervo Sural/patologiaRESUMO
A 1-month-old boy was admitted because of failure to thrive. He was floppy and had bilateral ptosis, diminished reflexes, and poor suck. He had aspiration pneumonia, developed seizures, and died at age 3 1/2 months. Laboratory data showed lactic acidosis, proteinuria, glycosuria and generalized aminoaciduria. He was an only child, and family history was negative. Muscle biopsy showed large clumps of granules positive with oxidative enzyme stains and increased lipid droplets. Ultrastructural studies showed large aggregates of mitochondria, many of which were greatly enlarged and contained disoriented or concentric whorls of cristae and paracrystalline inclusions. Cytochrome c oxidase was absent in fresh frozen sections by histochemical staining. By biochemical assay, cytochrome c oxidase (cytochrome aa3) was 6% of normal in muscle biopsy and undetectable in autopsy muscle; spectra and content of cytochromes showed lack of cytochrome aa3, decreased cytochrome b and normal cytochrome cc1. In kidney, cytochrome-c-oxidase activity was 38% of normal and spectra showed decreased cytochromes aa3 and b. The association of fatal infantile mitochondrial myopathy, lactic acidosis and renal dysfunction was previously reported by Van Biervliet et al and appears to be a distinct nosologic entity, one of the few biochemically defined mitochondrial myopathies.
Assuntos
Deficiência de Citocromo-c Oxidase , Doenças do Recém-Nascido/etiologia , Nefropatias/etiologia , Mitocôndrias Musculares/ultraestrutura , Doenças Musculares/etiologia , Carnitina O-Palmitoiltransferase/metabolismo , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Histocitoquímica , Humanos , Lactente , Recém-Nascido , Doenças do Recém-Nascido/patologia , Nefropatias/enzimologia , Nefropatias/patologia , Masculino , Músculos/enzimologia , Músculos/ultraestrutura , Doenças Musculares/enzimologia , Doenças Musculares/patologia , NADH Desidrogenase/metabolismo , Succinato Citocromo c Oxirredutase/metabolismoRESUMO
We report a generalized polyneuropathy coincident with the occurrence of graft-versus-host disease in four patients undergoing bone marrow transplantation and accompanying solid organ rejection (heart and kidney) in two patients. The neuropathy affected proximal and distal muscles, demonstrated hyporeflexia or areflexia, and usually had elevated CSF protein. Electrophysiologic studies did not meet strict criteria for demyelination. The signs of neuropathy improved after immunosuppressive treatment or simultaneous to the resolution of graft-versus-host disease or tissue rejection. Polyneuropathy must be considered as a potential complication of tissue transplantation.
Assuntos
Doença Enxerto-Hospedeiro/complicações , Doenças do Sistema Nervoso Periférico/complicações , Adulto , Transplante de Medula Óssea , Proteínas do Líquido Cefalorraquidiano/análise , Eletrofisiologia , Doença Enxerto-Hospedeiro/metabolismo , Transplante de Coração , Humanos , Transplante de Rim , Masculino , Pessoa de Meia-Idade , Doenças do Sistema Nervoso Periférico/metabolismo , Doenças do Sistema Nervoso Periférico/fisiopatologiaRESUMO
We treated eight patients who had inclusion body myositis (IBM) with oral prednisone therapy, and we performed muscle biopsies before and after treatment. We documented the patients' clinical response to therapy and changes in serum CK. Although the serum CK level fell, muscle strength worsened after prednisone treatment. In addition, while inflammation decreased in the muscle biopsy specimens, the number of vacuolated and amyloid-positive fibers increased after oral prednisone therapy. These observations indicate that the inflammatory response in IBM may play a secondary role in the pathogenesis of IBM. The unique findings of intracellular amyloid deposits and rimmed vacuoles distinguishing IBM from other inflammatory myopathies, and recognition that suppression of inflammation has no effect on the clinical course, suggest that IBM may represent a degenerative muscle disorder.
Assuntos
Imunossupressores/uso terapêutico , Corpos de Inclusão/patologia , Miosite/terapia , Idoso , Creatina Quinase/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Músculos/patologia , Miosite/sangue , Miosite/patologiaRESUMO
We report the results of nine patients with inclusion body myositis treated with intravenous immunoglobulin in an open-label uncontrolled study. None of our patients improved on objective manual muscle testing or functional disability scores. One patient developed mild neutropenia, complicating the intravenous immunoglobulin treatment. Our results do not exclude the possibility that intravenous immunoglobulin could be beneficial in some patients by slowing the rate of deterioration or perhaps stabilizing the disease. However, given the lack of objective improvement and high cost of treatment, we would not recommend intravenous immunoglobulin in the treatment of inclusion body myositis unless a blinded, controlled trial demonstrates clear benefit.
Assuntos
Imunoglobulinas Intravenosas/uso terapêutico , Corpos de Inclusão , Miosite/terapia , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
OBJECTIVES: 1) To determine the degree and distribution and quantitate the severity of autonomic impairment in painful neuropathy (PN). 2) To assess the role of autonomic testing in evaluating PN. METHODS: The authors studied 92 patients with PN (60 women and 32 men, age 56.9 +/- 12.4 years) using: 1) autonomic reflex testing (ART), Quantitative Sudomotor Axon Reflex Test (QSART), cardiac-vagal, head-up tilt, and surface skin temperature; 2) autonomic symptoms questionnaire; 3) nerve conduction (NCS) and laboratory studies; 4) quantitative sensory testing; 5) skin biopsy; and 6) Composite Autonomic Symptoms Score (CASS) scale to grade ART results from 0 (normal) to 10 (autonomic failure). RESULTS: Autonomic involvement in PN had characteristic features. Main symptoms were pain, secretory and skin vasomotor signs, hypertension, and impotence. ART results were abnormal in 86 (93.5%) (CASS < 4), QSART in 67 (72.8%), cardiac-vagal index in 58 (63%), skin temperature in 51 (55.4%), orthostatic hypertension in 39 (42.3%), and family history of PN in 26 (21%) of patients. Group 1 (abnormal NCS) (n = 45) had more severe ART and sensory abnormalities than the Group 2 (normal NCS) (n = 47): 1) CASS 2.0 +/- 0.96 vs 1.55 +/- 0.88 (p < 0.01), cardiac-vagal index (p < 0.02), skin temperature (p < 0.02), hypertension (p < 0.03), cooling (p < 0.002), and vibration (p < 0.0005) thresholds. CONCLUSIONS: Autonomic symptoms in painful neuropathy are predominantly cholinergic and form a unique constellation of features that are distinct from other autonomic neuropathies.